news & events -小9直播体育免费直播下载ios

dec.1, 2021, tot biopharm international company limited (tot biopharm, 1875.hk) announced its self-developed pusintin® (tab008, bevacizumab injection) has been officially granted approval by the national medical products administration (“nmpa”) f…

on november 9th, the groundbreaking ceremony ofthe global r&d center of tot biopharm was successfully completed. amongattendees of the ceremony including mi shen, member of the standing committeeof the cpc suzhou municipal committee and secretary of t

on may 31, 2021, tot biopharm (stock code:1875.hk) announced that its self-developed temozolomide capsules (toz309) obtained marketing approval from the national medical products administration (nmpa) for the treatment of (1) newly diagnosed glioblastoma